Novo Nordisk, with data on-hand from a late-stage trial of IcoSema, is preparing for an FDA filing in type 2 diabetes slated for the second …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Alex Atwood. Below is how Alex describes himself on LinkedIn. I’ve
The study found that consuming a beverage sweetened with sucrose significantly increased bacterial endotoxin levels in the blood, a marker for inflammation and gut barrier